Literature DB >> 19631972

Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration.

Cecelia A Powless1, Jamie N Bakkum-Gamez1, Giovanni D Aletti1, William A Cliby2.   

Abstract

OBJECTIVE: The relative value of abdominal exploration, lymphadenectomy, omentectomy and random peritoneal biopsies in the staging of apparent early stage epithelial ovarian cancer (EOC) has not been rigorously evaluated. We sought to define the clinical significance of random peritoneal biopsies of otherwise benign appearing tissues in staging of grossly early EOC.
METHODS: All patients with apparent early stage EOC undergoing staging from 1/1994 to 12/2003 were evaluated to identify surgical-pathologic findings responsible for upstaging at time of exploratory surgery. Demographics, surgical findings and operative outcomes were abstracted.
RESULTS: A total of 211 patients with apparent early EOC were included. Only 9 patients were upstaged based on pathology indicating a high negative predictive value of thorough exploration and lymphadenectomy. One patient (1/118; 0.8%) was upstaged from stage I disease to stage II disease based on random biopsy of pelvic peritoneum: all other stage II patients had visible disease. No patients were upstaged from stage I disease to stage III disease due to random biopsies or microscopic omental disease. Eight patients (3.8%) were upstaged from stage II to stage III disease based on random biopsies of upper abdominal peritoneum or the omentum.
CONCLUSIONS: In our study of apparent early stage EOC, random peritoneal biopsies and omentectomy added little diagnostic value beyond careful inspection of all peritoneal surfaces when EOC is grossly limited to the ovaries. Within our study, less than 4% of patients with pelvic metastasis were upstaged due to these particular staging procedures. No patients in our cohort had a change in treatment recommendations based on these biopsies.

Entities:  

Mesh:

Year:  2009        PMID: 19631972     DOI: 10.1016/j.ygyno.2009.06.037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  A Metastatic Gastric Tumor from Ovarian Cancer.

Authors:  Mitsuhiro Kono; Yasuaki Nagami; Masaki Ominami; Taishi Sakai; Takeshi Fukuda; Shusei Fukunaga; Fumio Tanaka; Satoshi Sugimori; Hirokazu Yamagami; Tetsuya Tanigawa; Masatsugu Shiba; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

2.  Gastric metastasis of ovarian serous cystadenocarcinoma.

Authors:  Shiqiang Yang
Journal:  Int Med Case Rep J       Date:  2018-09-05

3.  Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types.

Authors:  Sebastien Gouy; Marine Saidani; Amandine Maulard; Matthieu Faron; Slim Bach-Hamba; Enrica Bentivegna; Alexandra Leary; Patricia Pautier; Mojgan Devouassoux-Shisheboran; Catherine Genestie; Philippe Morice
Journal:  Gynecol Oncol Rep       Date:  2017-09-01

4.  Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers.

Authors:  Celine Montavon; Uzma Mirza; Andre Fedier; Andreas Schoetzau; Rosanna Zanetti Dällenbach; Viola Heinzelmann-Schwarz
Journal:  Exp Ther Med       Date:  2018-03-13       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.